For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Pharmagenesis, Inc.

USPTO Granted Patents = 25

EPO Patents = 1

Forward Citations = 268

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

John H Musser (19 out of 113 patents)

Dongcheng Dai (11 out of 50 patents)

John M Fidler (4 out of 6 patents)

4. Hongwei Yuan (4 out of 4 patents)

5. Edwin S Lennox (4 out of 7 patents)

6. Jian Wang (2 out of 24 patents)

7. Jinhua An (2 out of 4 patents)

8. Gary Allan Strobel (2 out of 58 patents)

9. You Mao Qi (2 out of 2 patents)

10. Nathan B Pliam (2 out of 2 patents)

11. Ke Li (1 out of 33 patents)

12. Rensheng Xu (1 out of 3 patents)

13. Karen S Leu (1 out of 1 patent)

14. Glenn D Rosen (1 out of 5 patents)

15. Concepcion Martinez-Miller (1 out of 1 patent)

25 patents: Sort by Forward Citations

1. 8617906 - Identification and screening of triptolide target molecules (2013-12-31),

2. 8426616 - Triptolide lactone ring derivatives as immunomodulators and anticancer agents (2013-04-23),

3. 8268882 - Triptolide C-ring derivatives as anticancer agents and immune modulators (2012-09-18),

4. 8048914 - [object Object] (2011-11-01),

5. 7863464 - Triptolide lactone ring derivatives as immunomodulators and anticancer agents (2011-01-04),

6. 7847109 - Triptolide derivatives for modulation of apoptosis and immunosuppression (2010-12-07),

7. 7820834 - Triptolide 5,6-derivatives as immunomodulators and anticancer agents (2010-10-26),

8. 7662976 - Triptolide derivatives for modulation of apoptosis and immunosuppression (2010-02-16),

9. 7417069 - Halogenated triptolide derivatives as immunomodulators and anticancer agents (2008-08-26),

10. 7098348 - Triptolide derivatives as immunomodulators and anticancer agents (2006-08-29),

11. 7019151 - Triptolide derivatives as immunomodulators and anticancer agents (2006-03-28),

12. 6991817 - Acid-modified arabinogalactan protein composition (2006-01-31),

13. 6949510 - Uses of diterpenoid triepoxides as an anti-proliferative agent (2005-09-27),

14. 6943259 - Halogenated triptolide derivatives as immunomodulators and anticancer agents (2005-09-13),

15. 6620843 - Anticancer treatment using triptolide prodrugs (2003-09-16),

Pharmagenesis, Inc. is a leading pharmaceutical company providing innovative healthcare solutions. With a team of dedicated professionals and cutting-edge research facilities, we strive to develop and deliver high-quality medications to improve patient outcomes. Our focus is on developing therapies for various medical conditions, including cardiovascular diseases, central nervous system disorders, and oncology. Visit our website to learn more about our company and latest research projects.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

25 Patents

#76 in Redwood City, CA

#3,062 in California

#12,934 in US

#24,953 in the World

Redwood City, CA, United States of America

Pharmagenesis, Inc.

Forward Citations = 268

21 inventors:

John H Musser (19 out of 113 patents)

Dongcheng Dai (11 out of 50 patents)

John M Fidler (4 out of 6 patents)

4. Hongwei Yuan (4 out of 4 patents)

5. Edwin S Lennox (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…